Eris Lifesciences informs about disclosure

09 Nov 2023 Evaluate

Eris Lifesciences has informed that the Company has availed a Term Loan Facility from Citi Bank N.A. amounting to Rs 280,00,00,000 for financing the acquisition of the Nephrology and Dermatology businesses pertaining to the Indian Territory of Biocon Biologics as informed by the Company on November 08, 2023. In accordance with requirement of regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para B (5) of Part A of Schedule III and SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, details attached shall be taken on record.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

1278.45 5.15 (0.40%)
11-Mar-2025 10:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.05
Dr. Reddys Lab 1118.70
Cipla 1449.20
Lupin 1981.00
Zydus Lifesciences 898.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...